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1. Introduction
Over the past few decades the reliance on cultured shrimp for 
food production has increased greatly. From 1970 to 2006, 
production of cultivated shrimp increased 350-fold, while shrimp 
yields from capture fisheries increased only 3-fold [1]. By the end 
of this period, yields from both industries were close to parity [1]. 
Despite this remarkable growth, shrimp aquaculture has not been 
without problems and during the early 1990’s it was estimated 
that approximately 40% of the world production capacity was 
being lost due to newly emerging diseases. In economic value, 
this lost production equated to over US$3 billion [2,3]. Other 
estimates put the value of the economic loss in the fifteen years 
up to 2001 at around US$15 billion [4]. 
Viral diseases in cultured shrimp have been estimated to 
contribute up to 60% of the annual losses in global productivity 
[4]. Much of the loss has been the result of major epidemics and 
viral outbreaks. The first of these events occurred in the mid to 
late 1980’s in Taiwan, with outbreaks of Monodon baculovirus 
(MBV). Subsequent to this, in the late 1980’s and early 1990’s 
Asian shrimp farms were impacted by Yellow-head virus (YHV) and 
farms in the Americas were affected by infectious hypodermal and 
hematopoietic necrosis virus (IHHNV) and Taura syndrome virus 
(TSV) [4-9]. The largest impact of all were losses caused by white 
spot syndrome virus (WSSV), originating in the early 1990’s in Asia 
and spreading to the America’s by the end of that decade [8].
Antiviral immunity and protection in penaeid shrimp
1 School of Biological Sciences,
 The University of Queensland,
 St. Lucia, QLD 4072, Australia
2CSIRO Food Futures National Flagship,
 CSIRO Animal, Food & Health Sciences,
 St Lucia, QLD, 4067 Australia
Darren J. Underwood1, 
Jeff A. Cowley2,
Karyn N. Johnson1* 
Received 22 December 2012
Accepted 17 May 2013
Abstract
The global aquaculture of penaeid shrimp has recently undergone a huge 
expansion resulting in production near parity with quantities trawled from 
the wild. Despite this apparent success, the industry has been hindered 
by diseases, predominantly from virus infection, which result in losses 
that have been estimated at 40% of the global production capacity. An 
increased research focus on penaeid immune response to virus infection 
has ensued, with an emphasis on harnessing the immune system to protect 
cultured shrimp from virus infection. Here we review the current knowledge 
of the factors implicated in the penaeid shrimp immune response to viral 
infection and strategies based on these discoveries that have been 
examined as potential avenues for disease control. Immune priming 
has been observed in response to challenge with White spot syndrome 
virus following prior exposure to virus or viral components. We review the 
protection achieved following immune priming with these components, 
the specificity and duration as well as the generality of the response and 
discuss potential mechanisms that may facilitate immune priming. In 
addition we highlight challenges associated with future research directions.
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The economic and social impact of viral disease on 
aquaculture of penaeid shrimp has prompted concerted research 
efforts into understanding the immune capabilities and defense-
responses of shrimp following challenge. It has also prompted 
many and varied control measures to be implemented at both 
hatcheries and farms, including for example, the molecular 
screening of hatchery broodstock and post-larvae for viral 
infection and the widespread transition from farming Penaeus 
monodon to farming Litopenaeus vannamei bred and certified 
to be specific pathogen free (SPF) [8,10]. Disease control by 
prophylactic methods is also being investigated (for review see 
Hauten, 2012 [30]) and understanding the crustacean immune 
system and how it interacts with viruses lays the platform for 
developing therapeutics.
Despite these management-based responses for control 
of viral diseases, it has been suggested that disease including 
viral disease will continue to hinder the production of farmed 
crustaceans [11]. In a recent review, Stentiford and colleagues 
[11] proposed a list of guidelines that were developed to address 
the impact of disease on aquaculture related food security. 
Within these guidelines they suggest, “An increased focus is 
required on effective therapeutics for invertebrate pathogens 
and specifically those disease-causing agents affecting food 
production from aquaculture”, highlighting a need for a better 
understanding of the immune system of crustaceans and how 
viruses interact with their host.
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PRPs associated with the recognition of viruses by penaeid 
shrimp are not as well defined. 
Despite this, genes encoding lectin-like proteins with 
proposed roles in pathogen recognition, as well as small 
GTPases expected to be involved in virus infection and cellular 
trafficking, have been identified to have antiviral defense roles 
in penaeid shrimp. Most data has emanated from studies 
of gene expression changes in response to WSSV infection 
[34-47]. Lectins are believed to have roles in non-self recognition 
in invertebrates [48,49]. However, the range of immune functions 
undertaken by the superfamily of proteins containing C-type 
lectin-like domains (CTLDs) is highly diverse [50]. 
Proteins containing CTLDs are grouped by their differing 
recognition domains which include carbohydrate recognition 
domains (CRDs) and domains recognizing non-sugar ligands 
[51]. Various penaeid shrimp proteins with CTLDs have been 
studied including those characterised by CRDs [52-54]. PmAV 
and PmLT are among the CTLD-containing proteins regulated 
differentially in response to WSSV [53,54]. While not possessing 
agglutination activity, PmAV has been shown to have antiviral 
properties as demonstrated in fish, in which a recombinant 
PmAV protein strongly inhibited iridovirus replication [53]. In 
shrimp, PmAV expression levels drop 12 hours post-WSSV 
infection before becoming elevated 3 to 4 days later [55]. PmLT 
expression levels also drop by 2 hours post-WSSV infection but 
return to normal levels by 4 hours post-infection [54].
GTPase Ras superfamily members function as molecular 
switches [56] and have been grouped into five major branches by 
differences in structure and function [57]. Much of the experimental 
data reported in the literature has focused on proteins in the Rho 
family (Ras homologs) that control many signal transduction 
pathways, have an integral role in actin cytoskeleton regulation [58] 
and are in the Rab family, the largest within the Ras superfamily 
[57]. Rab GTPases have roles in vesicular transport and protein 
trafficking and thus in the endocytosis and secretory pathways 
[59,60]. In humans, Rab7 trafficking has been localised to late 
endocytosis pathways and Rab6a localised to Golgi traffic [61].
In response to WSSV infection, the PmRab7 protein has been 
shown to bind to the virion envelope protein VP28 and to lead 
to a decrease in P. monodon mortality [62]. Despite PmRab7 
expression levels remaining stable in response to WSSV infection, 
injection of shrimp with dsRNA specific to PmRab7 results in 
reduced WSSV replication, and also reduced YHV replication 
[63,64]. Another study found PmRab7 expression to increase in M. 
japonicus in response to injection of DNA-based vaccine to WSSV 
[65]. Also in M. japonicus, WSSV infection elevates expression of 
PjRab, a Rab6-like gene, between 8 and 72 hours post-injection 
[66] and alters expression of a Rho-like gene as determined by a 
suppression subtractive hybridization (SSH) analysis [39]. PjRab 
is also involved in haemocytic phagocytosis and silencing of its 
expression causes WSSV infection loads to increase [67].
2.1.2 DSCAM
Recently, the Down syndrome cell adhesion molecule (DSCAM) 
receptors have been implicated in the invertebrate immune 
With this goal in mind, the following review focuses on 
antiviral immunity in penaeid shrimp and more specifically 
protection of shrimp from viral diseases by prior exposure 
to viral components. A brief background on penaeid shrimp 
antiviral immunity is provided before discussion of the literature 
on WSSV priming protection, what is known of the mechanism, 
the potential for further investigation and difficulties associated 
with such research. 
2. Penaeid immune responses
Like vertebrates, invertebrates require effective immune 
responses to protect themselves against potentially pathogenic 
viruses, bacteria or fungi. In vertebrates, both innate and adaptive 
immune systems are utilized to defend against pathogens 
and these systems are comparatively well understood [12]. 
Invertebrates, however, do not possess an adaptive immune 
response that utilises immunoglobulin [13]. Despite this, they 
have well developed innate defense mechanisms reliant on non-
self recognition that provide a non-specific, yet highly effective, 
defense response to pathogen invasion [14-20]. As invertebrates 
are highly diverse, it is important to examine immune responses 
in diverse phyla and species within these to identify what 
common and unique mechanisms are employed [19]. Such 
knowledge across diverse invertebrates will also instruct as to 
what immune strategies can be applied universally or otherwise 
to control disease. While this is important for the many farmed 
crustacean and mollusk species that command high commercial 
values, understanding host responses to infection and disease 
is also important in invertebrates that are agricultural pests or 
disease vectors for humans [19].
The innate pathogen defense system of invertebrates 
encompasses various defense systems responsible for a rapid 
response to bacterial, fungal and viral pathogens; many of which 
are conserved in the innate immune response of vertebrates 
[21,22]. The major innate host-defense systems of invertebrates 
include: haemolymph coagulation, pro-phenoloxidase (proPO) 
activation, lectin-complement, agglutinin-lectin, reactive oxygen 
species, phagocytosis and the antimicrobial peptides (AMPs) 
that are mediated by Toll-like receptors and the immune-
deficiency (IMD) pathways [14,15]. However, how invertebrates 
respond to viral infections is not as well understood as how they 
respond to bacterial or fungal infections.  
2.1 Penaeid antiviral immune responses
2.1.1 Pattern recognition proteins
Stimulation of the innate invertebrate immune response by 
recognition of pathogen-associated molecular patterns (PAMPs) 
is well characterised in response to bacterial and fungal 
pathogens [15,16,23-30]. The recognition of PAMPs by a variety 
of pattern recognition proteins (PRPs) such as peptidoglycan- or 
β-glucan-binding proteins is conserved amongst invertebrates 
including penaeid shrimp [31-33]. These PRPs induce the major 
innate host-defense systems of invertebrates. The PAMPs and 
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no activity against the virus [80]. Various penaeidins have also 
been demonstrated to have activity against viruses [65,78,83] in 
the penaeid shrimp innate immune response. The determination 
of why various AMPs appear to differ in activity among differing 
shrimp species warrants further investigation.
2.1.4 RNAi
The RNAi pathway was first discovered in the nematode 
Caenorhabditis elegans [84] and has since been found to exist in 
most invertebrate and plant species [85,86].
RNA interference (RNAi) responses in shrimp can be mounted 
in three ways, with one of these, the small interfering RNA (siRNA) 
pathway, playing a major role in viral defense [85,87-91]. In the 
siRNA pathway, Dicer-2 cleaves long, virus-specific double-
stranded RNA (dsRNA) into ~21 bp siRNAs that are incorporated 
into the RNA-induced silencing complex (RISC) as the Dicer-2 
enzyme forms a heterodimer with R2D2. One strand of the siRNA 
is used as a template to associate with viral RNA in a sequence 
specific manner and the Argonaut-2 (Ago-2) enzyme facilitates 
cleavage of the complementary viral RNA, thus interfering with 
viral replication and protein expression [84,92-94]. 
The RNAi pathway plays a significant role in antiviral 
immunity of penaeid shrimp and various responses induced 
by dsRNA have been demonstrated [95]. Components critical 
to the functioning of the RNAi pathway including the Dicer 
and Argonaute enzymes have also been identified in shrimp 
[96-98]. There is evidence that both specific as well as non-
specific stimulation of the RNAi pathways can have antiviral 
affects, and when delivered exogenously, long dsRNAs are far 
more effective and specific in their action compared to siRNAs 
[95,99]. This non-specific innate antiviral action induced by 
dsRNA was long thought to be restricted to vertebrates; it’s 
action in invertebrates likely acts through a different pathway to 
the sequence specific RNAi response. 
2.1.5 JAK/STAT 
In Drosophila sp., the JAK/STAT pathway is well characterized, 
with genes involved in the JAK/STAT pathway activated in 
response to viral infection but not to bacterial or fungal infection 
[100]. To stimulate the pathway, various unpaired ligands (ie. UPD, 
UPD2 and UPD3) bind the Domeless receptor, a transmembrane 
protein responsible for signaling through Hopscotch and 
STAT92E, and phosphorylated STAT is transported to the nucleus 
where it promotes expression of genes like tep1 and totA which 
are involved in humoral immune responses. The tep1 gene 
encodes one of a family of thioester-containing proteins (TEPs) 
with similarities to the superfamily of complement proteins. 
The totA gene also encodes a protein suggested to promote 
phagocytosis in a complement-like manner [101].
The JAK and STAT components critical to functioning JAK/
STAT pathways used by Drosophila sp. for pathogen protection 
have been found to be stimulated in shrimp in response to viral 
challenge [102,103]. Components of the JAK/STAT pathway 
have been described from multiple species of penaeid shrimp, 
including a STAT from the Chinese white shrimp Fenneropenaeus 
response. Initially identified in Drosophila melanogaster, the 
hyper-variable gene encoding the receptors was found to 
be capable of translating thousands of protein isoforms via 
alternative splicing of precursor mRNAs [68]. DSCAM receptors 
are believed to have roles in immunity through a process where 
the different isoforms act to variably identify PAMPs [69]. The 
finding that D. melanogaster DSCAM loss of function mutants 
have inhibited phagocytic uptake of bacteria [70] supports this 
hypothesis. In shrimp, DSCAM receptors have been identified in 
P. monodon and L. vannamei [71,72] and it is hypothesized that 
different PAMPs (including those derived from viruses) result in 
alteration of the variable domains [30,72,73].
2.1.3 Antimicrobial peptides
In response to the recognition of PAMPs the humoral immune 
response of invertebrates is mediated by antimicrobial peptides. 
In Drosophila sp., AMPs are synthesized primarily in the fat body 
for secretion into the haemolymph [28]. Of the AMPs, seven 
distinct families have been studied extensively. These families 
include: (i) Drosomycin and (ii) Metchnikowin, which are produced 
predominantly in response to fungi, (iii) Attacins, (iv) Cecropins, 
(v) Diptericins and (vi) Drosocin, produced predominantly in 
response to Gram-negative bacteria, as well as (vii) Defensin, 
which is produced predominantly in response to Gram-positive 
bacteria [74,75]. 
These AMPS have been characterized in most detail in 
Drosophila sp., but many related peptides have been found across 
diverse invertebrate species [16,23,74,76,77]. In penaeid shrimp 
AMPs have been reported with activity against a wide range of 
pathogens including Gram-positive and Gram-negative bacteria, 
fungi and viruses. Some important AMP families include: crustins, 
which have been identified in a wide range of crustaceans. The 
haemocyte expressed 7-14 kDa proteins have a characteristic 
whey acidic protein (WAP) domain and have varying reports on 
antimicrobial activity in penaeid prawns [47,78]. Penaeidins, 
a family of four classes of AMPs, are characterised by an 
N-terminal proline-rich domain and a C-terminal cysteine rich 
domain. The expression of these small proteins (5-7 kDa) differs 
between species and as with crustins, differing antimicrobial 
activity has been reported in various studies [30,79]. Along with 
penaeidins and crustins, important immune roles are associated 
in shrimp with Anti-Lipopolysaccharide Factor (ALF). ALFs are 
AMPs that can provide broad-spectrum pathogen defense in 
shrimp [47,80,81]. Hauten [30] and Rowley and Pope [82] have 
reviewed the literature on these AMPs extensively, including 
details about which AMPs are active against which pathogens 
in penaeid shrimp. 
The implication of various AMPs in antiviral responses 
is established, however the activity does not always appear 
consistent depending on the pathogen and host species. For 
example, activity of crustins against WSSV and YHV infection has 
been reported in L. vannamei and P. monodon [47,78], however 
no activity was observed in another study of WSSV infection 
in M. japonicus [65]. A similar pattern is seen with ALFs; one 
study reporting activity against YHV [47], while another reports 
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3.1 WSSV immune priming
At least for WSSV, which has been investigated in most detail 
as a model challenge system, immune priming induced through 
prior exposure to virus or viral components has been shown 
to be effective in protecting penaeid shrimp from developing 
disease following challenge with a normally lethal dose of virus. 
Pre-exposure to either virus particles or envelope glycoproteins 
can provide protection in multiple different penaeid species 
[120-124]. The amount and longevity of protection can vary 
depending on pre-exposure variables and multiple studies have 
investigated these factors utilizing different methods of priming 
and varied penaeid species. For the purpose of this review, we 
will refer to these studies as “immune priming assays” to avoid 
any confusion with vaccination relying on antibody mediated 
immune priming. While the mechanisms of immune priming in 
invertebrates remain unknown, it is important that the distinction 
between this protective response and adaptive immunity is 
maintained [125]. A summary of the major immune priming 
assays is provided in Table 1 [65,120-124,126-135]. A schematic 
representation of the WSSV virion is shown in Figure 1, which 
also outlines the virion location of the proteins and components 
used in immune priming assays [136].
Protection against WSSV challenge was first demonstrated 
by pre-exposure of M. japonicus to a sub-lethal dose of WSSV 
[124].  Pre-exposure to WSSV led to a significant increase in 
survival rates 3 to 4 weeks post-challenge compared to not-
exposed control shrimp and protection persisted for a further 
month [124]. However, when re-challenged 3 months after 
immune priming, the immune primed shrimp died at a rate similar 
to the control shrimp, suggesting that the protective mechanism 
chinensis [104]. JAK and STAT have also both been identified 
in the Brine shrimp, Artemia franciscana [105]. In P. monodon, 
WSSV has been shown to activate STAT [102,103].
2.1.6 Apoptosis
Another cellular response associated with viral infection in 
shrimp is apoptosis: the mechanism of programmed cell death, 
with roles in eliminating unhealthy or unnecessary cells. Genes 
related to apoptosis are often reported to be up- or down-
regulated in response to viral infection, however it is not well 
established whether apoptosis plays a role in viral immunity and 
conflicting results have resulted in this distinction becoming 
controversial. Some studies report apoptosis playing a major role 
in defense by removal of dangerous cells, such as those that may 
be viral infected [106]. Contrary to another study showing that 
knockdown of caspase-3, a key gene in the apoptosis pathway, 
resulted in reduced mortality in P vannamei [107]. Another study 
found that apoptosis was not important in the protection of P. 
japonicus that were resistant to subsequent WSSV infection after 
previous exposure [108]. 
3. Immune priming 
Invertebrates rely solely on the innate immune system for 
pathogen defense which has long been considered to lack 
memory or inducible elements related to those mediating the 
adaptive immune response of vertebrates. Contrary to this 
belief, it has now become accepted that some form of inducible 
response which may include elements of memory, exists in 
invertebrates and this response can be primed for pathogen 
defense [15,16,76,109-112]. Past exposure to a pathogen, or 
pathogen components has been shown to result in immune 
memory or ‘priming’ (reviewed by Little and Kraaijeveld, [113]; 
Sadd and Schmid-Hempel, [114] and Johnson et al. [115]). 
Since invertebrates lack the necessary machinery, the factors 
and mechanisms involved must be different to the conventional 
definition of vaccination described in vertebrate animals, which 
involves the anticipatory effect of immunoglobulins, T cells and 
the Major histocompatibility complex (MHC) [116,117].
Although not utilizing the same components as the 
vertebrate adaptive immune response, invertebrate immune 
priming has functional similarities. For example, in Macrocyclops 
albidus copepods parasitized by Schistocephalus solidus, 
prior exposure to related but not unrelated parasites has been 
found to reduce infection severity [118]. Increased protection 
with narrow specificity has also been noted in the bumblebee 
Bombus terrestris challenged subsequently with homologous 
bacteria [114]. In Drosophila sp., specific activation of the 
Toll pathway is capable of elucidating differential response to 
various microorganisms, including specific response to fungal 
pathogens [119]. These examples, including the immune 
discrimination in Drosophila to different classes of organisms 
show that there is at least some specificity in invertebrate 
immunity. However, the mechanisms of immune priming are 
not well understood.
Figure 1.  Schematic representation of the White spot syndrome virus 
particle. Illustration of the WSSV virion showing envelope 
glycoproteins (circles) and tail-like projection (black tail) and a 
cut away diagram showing the virus envelope, tegument and 
nucleocapsid (white cylinder). The major structural proteins 
and WSSV proteins used in vaccination trials and their location 
in the virion are noted. [136].
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Table 1.  Summary of WSSV immune priming assays by year.
Reference Vaccine Details Response (RPS) *
Wu et al. [66] Live virus Single injection of a sub-lethal dose of live virus
1 month = 67%
2 months = 54%
3 months = 6%
Namikoshi et al. [120]
Inactivated
Recombinant protein
Single injection of heat-inactivated virus
Single injection of formalin-inactivated virus
Single injection of VP26 tegument protein
Injection and booster of VP26 tegument protein
Single injection of VP28 envelope protein
Injection and booster of VP28 envelope protein
10 days = 15%
30 days = 30%
10 days = 55%
30 days = 5%
10 days = 57%
10 days = 60%
10 days = 17%
10 days = 95%
Witteveldt et al. [123] Recombinant protein
Single injection of VP19 envelope protein
Single injection of VP19 + VP28 envelope protein mix
Single injection of VP28 envelope protein
2 days = 33%
25 days = 57%
2 days = 33%
25 days = 41%
2 days = 44%
25 days = 21%
Witteveldt et al. [122] Recombinant protein Oral vaccination with VP19 envelope proteinOral vaccination with VP28 envelope protein
2 days = 44%
3 days = 64%
7 days = 77%
21 days = 29%
Singh et al. [133] Inactivated Oral vaccination with formalin-inactivated virus
1 day = No protection
5 days = 100%
10 days = 100%
15 days = No protection
Vaseeharan et al. [135] Recombinant protein Single injection of VP292 envelope proteinInjection and booster of VP292 envelope protein
30 days = 41%
30 days = 52%
Rout et al., [121] DNA vaccine
Injection of DNA vaccine from nucleocapsid VP15
Injection of DNA vaccine from envelope VP28
Injection of DNA vaccine from nucleocapsid VP35
Injection of DNA vaccine from envelope VP281
25 days = No protection
50 days = No protection
25 days = 51%
50 days = 30%
25 days = No protection
50 days = No protection
25 days = 46%
50 days = 34%
Ha et al., [128] Recombinant protein
Single injection of VP19 envelope protein
Single injection of VP466 envelope protein
Oral vaccination of VP19 envelope protein
Oral vaccination of VP466 envelope protein
22 days = 50%
22 days = 51%
25 days = 50%
25 days = 48%
Caipang et al., [126] Recombinant protein Oral vaccination of VP28 envelope protein 3 days = 81% (Avg)2 weeks = 24% (Avg)
Satoh et al., [132] Recombinant protein
Oral vaccination of VP26 tegument protein: oral challenge
Oral vaccination VP26 tegument protein: injection challenge
Oral vaccination VP26 tegument protein: immersion challenge
Oral vaccination of VP28 envelope protein: oral challenge
Oral vaccination VP28 envelope protein: injection challenge
Oral vaccination VP28 envelope protein: immersion challenge
10 days = 100%
10 days = 61%
10 days = 71%
10 days = 100%
10 days = 34%
10 days = 70%
Rajesh Kumar et al., 
[131]
DNA vaccine Injection of DNA vaccine from envelope VP28
7 days = 90%
14 days = 77%
21 days = 67%
30 days = 57%
Syed Musthaq et al., 
[134]
Recombinant protein Injection and booster of VP28 envelope protein 3 days = 86%15 days = 74%
Kono et al., [65] DNA vaccine Injection of DNA vaccine from envelope VP28 7 days = 70%
Fu et al., [127] Recombinant protein Oral vaccination of VP28 envelope protein 14 days = 83%
Mavichak et al., [130] Recombinant protein Oral vaccination with liposome adjuvant of VP28 envelope proteinOral vaccination with VP28 envelope protein 3 days = 68%3 days = 50%
Li et al., [129] DNA vaccine Injection of DNA vaccine from envelope VP28 7 days = 53%14 days = 20%
* Response is calculated as a relative percent survival (RPS): (1 – treatment group mortality/control group mortality) x 100
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of antigens might result in immune priming, shrimp were fed 
commercial feed pellets coated with inactivated bacteria in which 
recombinant VP19 and VP28 had been expressed prior to WSSV 
challenge [122]. As it is possible that a general immune response 
could be achieved from the presence of bacteria alone [139,140], 
the positive control shrimp were fed bacteria containing empty 
plasmid. Shrimp fed VP28 bacteria were protected against 
WSSV challenge; in contrast, shrimp fed VP19 bacteria were 
not protected. When challenged 3, 7 and 21 days after feeding 
on VP28 bacteria was ceased, survival rates of 64%, 77% and 
29%, respectively, were obtained relative to controls fed bacteria 
containing the empty plasmid. Although the difference in survival 
was not statistically significant when challenge was undertaken 
21 days after feeding, survival rates when challenged earlier 
were consistent with oral delivery of VP28 expressed in bacteria 
being capable of inducing an anti-WSSV immune response.
As an alternative strategy, to potentially increase the 
duration of the protective response, DNA vaccination based on 
intracellular protein delivery from a eukaryotic expression plasmid 
expression has been investigated [121]. Plasmids designed to 
express the VP15 and VP35 nucleocapsid-associated proteins 
and the VP28 and VP281 envelope proteins were each injected 
into the shrimp and intracellular gene expression from each 
plasmid was confirmed by RT-PCR amplification of the expected 
mRNA. Expression of only the VP28 and VP281 envelope proteins 
resulted in significantly lower shrimp mortality following WSSV 
challenge, with protection lasting for up to 7 weeks. Which is far 
longer than observed using other immune priming approaches. 
While the mechanisms involved remain to be determined, this 
prolonged protection is likely to be due to the extended ability 
of the vectors to continue expressing viral protein in host tissues 
[121]. A summary of the duration and protection provided by 
different viral components utilized in immune priming trials is 
presented in Figure 2 [120,121,124,135]. 
was transient. In another study protection was also achieved 
when M. japonicus were injected with formalin-inactivated 
WSSV, with and without immunostimulants, prior to challenge. 
This showed that the protective mechanism was not reliant on 
virus replication [120]. However, even in the best-case scenario 
of 30% survival over a 1-month period using heat-inactivated 
WSSV as an immune primer, the protection levels achieved were 
lower than using prior infection with a sub-lethal dose of WSSV 
[120,124]. Protection has also been achieved by immune priming 
using recombinantly expressed WSSV structural proteins. 
These include VP26, which is known to be associated with the 
virus tegument, and VP28, which is an envelope glycoprotein 
[137,138]. Significantly lower mortalities were observed after 
20 days post-challenge in shrimp exposed to protein subunits 
VP26 and VP28 and challenged with WSSV compared to non-
exposed controls [120]. Furthermore shrimp that survived 
subsequent challenge after WSSV component immune priming 
had reduced infection levels of WSSV, low enough that they were 
undetectable by one-step PCR [121-123]. 
Immune priming using a recombinant form of the WSSV 
VP19 envelope glycoprotein fused to maltose binding protein 
(MBP) also protects shrimp against disease and mortality when 
challenged either 2 days or 25 days post-exposure [123]. In 
contrast, recombinant WSSV VP28 envelope glycoprotein fused 
to MBP only provided similar levels of protection in shrimp 
challenged 2 days post-exposure, with no obvious protection 
provided to shrimp challenged 25 days post-exposure [123]. A 
mix of the recombinant VP19 and VP28 proteins again provided 
protection from challenge at 2 days post-exposure but not 25 
days [123]. 
With the potential for immune priming of shrimp to control 
viral infection being demonstrated by injection, other means of 
delivery more logistically feasible to shrimp aquaculture have 
been investigated. In a trial to examine whether oral delivery 
Figure 2.  Immune priming assay summary. Summary of the time and amount of protection afforded by exposure to various WSSV components prior to 
challenge. Time line showing the level of protection (RPS) in immune priming assays where challenge was administered at the longest period 
post-exposure. Immune priming by injection of a low-dose of live WSSV provided an RPS of 67% when challenged after 1 month, 54% when 
challenged after 2 months and 6% when challenged after 3 months [124]. Immune priming by injection of heat-inactivated WSSV resulted 
in an RPS of 15% when challenged after 10 days and 30% when challenged after 30 days [120]. Recombinant VP292 injection and booster 
injection resulted in an RPS of 52% when challenged at 30 days post-booster [135] and DNA vaccination of recombinant VP281 provided an 
RPS of 46% when subjected to challenge after 25 days and 34% when challenged with WSSV after 50 days [121]. No protection has been 
elucidated with recombinant nucleocapsid protein or DNA vaccine (as represented by red cross).
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understanding of the mechanisms, immune priming assays 
into cross-protection should incorporate viral proteins or DNA 
vaccines, as it is possible the mechanisms are different to those 
involved in response to live virus cross-protection.
In a recent study in which L. vannamei were exposed to 
the live bacterium Bacillus subtilus carrying recombinant VP28 
envelope glycoprotein, protection against WSSV challenge 
was found to be associated with elevated haemocytes 
phagocytosing WSSV [127,147]. However, no increase was 
observed in the numbers of haemocytes phagocytosing 
Taura syndrome virus (TSV), suggesting a selective or specific 
activation of the haemocyte response to VP28 [82]. Thus shrimp 
might use multiple mechanisms involving a specific haemocyte 
response quasi-comparable to the antibody-based memory 
response of vertebrates, and cell-specific response involving 
either the blocking or withdrawal for receptors essential for virus 
attachment and entry, as suggested previously [115].
4. Research directions
Research effort to identify and develop strategies to protect 
shrimp against virus disease has been largely reactionary due to 
the importance of viral disease to the aquaculture industry. With 
WSSV having the greatest impact on the industry worldwide 
[1,9,148], it is not surprising that protection strategies and 
immune responses to WSSV have been investigated in the most 
detail. Much has been learned from this research including: 
what immune-related genes are up- or down-regulated in 
response to infection and these may provide useful targets to 
promote protection; the impact of dsRNA-based interference 
on viral replication and potential use of this to control virus 
infection; and similarly the phenomenon of protein-based 
immune priming which can be harnessed to protect against 
virus challenge. However, while such information might result in 
commercial applications benefiting aquaculture, there remains 
much academic interest in unraveling the molecular mechanisms 
involved. Research on shrimp responses to viruses other than 
WSSV should help identify which immune mechanisms are 
generic or unique to WSSV. Moreover, while gene expression and 
bioinformatics analyses have identified many shrimp proteins 
with predicted immune function, confirming the function of these 
proteins using RNAi and other approaches is still in its infancy.
4.1 Persistent viral infections
As occurs in many invertebrates, persistent viral infection is 
common in shrimp. Many shrimp viruses are observed to persist 
where the host is tolerant to the virus and shows no overt 
symptoms of infection. The mechanism(s) for such tolerance are 
unknown (for review see Flegel, [1]). Most of the immune priming 
assays carried out to date have not investigated whether animals 
that are protected from challenge after prior-exposure to viral 
components show clearance of the virus or remain infected but 
are tolerant. This is a very important distinction in determining 
the mechanisms of protection, and in utilizing the response for 
practical applications. For some viruses like GAV that commonly 
3.2 Specificity and generality of protection
Until recently, WSSV was the only shrimp virus for which immune 
priming had been examined. The focus of the investigations 
using WSSV has been on achieving protection, with very little 
done to understand the underlying mechanisms [141]. Indeed 
the mechanisms involved in generating specific immunity, even 
if relatively short-lived compared to the memory responses of 
vertebrates, remain to be elucidated for any invertebrate species. 
Important questions for which answers are needed include 
whether protection afforded by the various immune priming 
strategies described earlier are WSSV-specific or generalized, 
and whether similar immune priming can protect shrimp against 
other viruses.
With WSSV, shrimp have only been protected against 
challenge when viral envelope glycoproteins have been included 
as a vaccine component. Therefore, to help discover the 
mechanism involved in protection, it will be useful to determine 
whether pre-exposure to envelope proteins or surface-exposed 
proteins of viruses with differing methods of cell attachment, 
entry and infection might also provide protective responses. 
One study addressed this question using Gill-associated virus 
(GAV), an enveloped shrimp virus containing a positive-sense 
single-stranded RNA genome, which is related to members of 
the Nidovirales. However, no protection was observed following 
immune priming of shrimp with GAV envelope glycoprotein 
components expressed and purified from bacteria [142]. Further 
research is needed to determine if protection can be achieved 
against other viruses or if other methods can be used to 
successfully protect against GAV.
3.3 Mechanisms of protection
The longest duration of protection has been achieved through 
non-lethal exposure to live virus and intracellular expression of 
envelope glycoproteins from expression plasmids, suggesting 
persistent exposure to viral protein may be required for continued 
protection [120-124,126,143]. The molecular mechanisms of this 
novel immune response are not fully understood. A model of 
viral accommodation where the virus is sustained at low levels 
has been put forward, where the host is not resistant to re-
infection but provided with a specific memory response capable 
of interfering with pathogenicity upon viral reinfection [144]. 
Another model proposed by Johnson et al. postulates that cell 
surface receptors required for viral uptake may bind specific viral 
proteins, blocking virus attachment and entry [115]. 
The specificity of immune priming responses remains 
unclear and as yet, cross-protection in shrimp has only been 
identified through sub-lethal infection of an unrelated virus. In 
cultured Penaeus stylirostris infected with IHHNV, a single-
strand DNA virus, protection against WSSV, a double-stranded 
DNA virus, has been noted [145,146]. Why this occurs remains 
unknown, but it would be useful to determine whether the 
viruses can infect the same cells and thus compete with each 
other, or whether prior cell infection by IHHNV might result in 
the withdrawal of cell surface receptors needed for attachment 
and entry of WSSV [1]. To develop this research and gain further 
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elevate heat shock protein expression in P. monodon [153] as 
well as cause increased susceptibility to bacterial infection [154]. 
In wild-captured P. monodon broodstock, repeated handling 
stress associated with bleeding has also been noted to markedly 
increase GAV infection levels in haemocytes [155].  
The potential for immune priming via oral delivery has also 
been investigated with promising results [122,123,128]. Generally 
utilizing feed coated with killed bacteria expressing recombinant 
viral proteins [122,123] and recently utilizing live bacteria 
[127,147]. Alternatively, enrichment and feeding of artemia in 
smaller animals may result in transfer of live probiotic bacteria 
into the gut [156]. Potentially, recombinant proteins could also be 
transferred into the gut this way. The fate of antigens in the gut 
remains uncertain and again, further investigation is required to 
determine if this is a feasible delivery method. 
4.3 Conclusions
To understand the immune priming response described in the 
WSSV-shrimp model a continued focus on determining the 
underlying mechanisms is required. This includes determination 
of whether a similar response is achieved in shrimp challenged 
with other viruses and whether protection displays cross-
specificity. It is interesting to note that almost 10 years have 
passed since the initial immune priming trials on WSSV and we 
are yet to see evidence of this type of response against any other 
virus. However, it is currently unclear whether this is indicative of 
a WSSV-specific mechanism or simply an outcome of the prior 
research focus. Future research driven by fundamental questions 
of penaeid response to virus infection will hopefully lead to a 
mechanistic understanding of this important phenomenon.
exist as persistent infections [149,150], tolerance of any pre-
existing infection might also be important to and interfere with 
the outcome of disease protection strategies based on immune 
priming. There is also potential for experimental outcomes of 
immune priming or immune response analysis to be confounded 
by persistent virus infection in experimental animals. The use of 
shrimp certified to be SPF or screened to be free of infection in 
such bioassays might thus be beneficial, as would analysis of 
protected shrimp to determine whether a similar tolerance state 
is established post-challenge.
4.2 Specificity and duration of protection and logistics of 
immune priming
As stated earlier, understanding the specificity, efficacy and 
longevity of various immune priming strategies will be important 
in their commercial application in shrimp aquaculture to 
control disease. Understanding the mechanisms allows the 
determination of how long it is possible to protect animals from 
disease and whether it is logistically feasible. This should be 
taken into account along with the efficacy of different methods 
of immune priming. As demonstrated in Table 1, many of the 
immune priming assays resulting in significant protection have 
relied on injection. There are logistical problems associated with 
using this method in aquaculture and it also raises concerns in 
regards to animal health following handling stress. Shrimp are 
very susceptible to compromised immunity from stress, with 
examples of this from multiple species. Sub-optimal levels of 
nitrate and ammonia and other water quality factors can suppress 
immune capability of P. japonicas [151], changes in salinity can 
similarly affect L. vannamei [152], temperature fluctuations can 
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